Cargando…
Hereditary Breast Cancer: The Era of New Susceptibility Genes
Breast cancer is the most common malignancy among females. 5%–10% of breast cancer cases are hereditary and are caused by pathogenic mutations in the considered reference BRCA1 and BRCA2 genes. As sequencing technologies evolve, more susceptible genes have been discovered and BRCA1 and BRCA2 predisp...
Autores principales: | Apostolou, Paraskevi, Fostira, Florentia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3618918/ https://www.ncbi.nlm.nih.gov/pubmed/23586058 http://dx.doi.org/10.1155/2013/747318 |
Ejemplares similares
-
One in three highly selected Greek patients with breast cancer carries a loss-of-function variant in a cancer susceptibility gene
por: Fostira, Florentia, et al.
Publicado: (2020) -
CHEK2 Pathogenic Variants in Greek Breast Cancer Patients: Evidence for Strong Associations with Estrogen Receptor Positivity, Overuse of Risk-Reducing Procedures and Population Founder Effects
por: Apostolou, Paraskevi, et al.
Publicado: (2021) -
Current practices on genetic testing in ovarian cancer
por: Fostira, Florentia, et al.
Publicado: (2020) -
Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges
por: Nikolaidi, Adamantia, et al.
Publicado: (2022) -
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)